Schonfeld Strategic Advisors’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$834K Sell
56,323
-69,475
-55% -$1.03M 0.01% 1282
2025
Q1
$2.25M Buy
125,798
+102,798
+447% +$1.84M 0.01% 803
2024
Q4
$401K Sell
23,000
-152,820
-87% -$2.66M ﹤0.01% 1433
2024
Q3
$2.46M Sell
175,820
-9,303
-5% -$130K 0.02% 683
2024
Q2
$1.52M Sell
185,123
-255,834
-58% -$2.1M 0.01% 907
2024
Q1
$3.4M Sell
440,957
-288,052
-40% -$2.22M 0.02% 650
2023
Q4
$6.55M Buy
729,009
+205,009
+39% +$1.84M 0.04% 409
2023
Q3
$4.68M Buy
524,000
+218,371
+71% +$1.95M 0.04% 486
2023
Q2
$4.69M Buy
305,629
+17,871
+6% +$274K 0.04% 504
2023
Q1
$6.47M Buy
+287,758
New +$6.47M 0.06% 379
2022
Q4
Sell
-27,964
Closed -$689K 2906
2022
Q3
$689K Sell
27,964
-13,145
-32% -$324K 0.01% 1504
2022
Q2
$996K Buy
41,109
+30,109
+274% +$729K 0.01% 958
2022
Q1
$284K Sell
11,000
-2,100
-16% -$54.2K ﹤0.01% 1662
2021
Q4
$407K Buy
13,100
+3,400
+35% +$106K ﹤0.01% 1304
2021
Q3
$235K Sell
9,700
-12,260
-56% -$297K ﹤0.01% 1603
2021
Q2
$320K Buy
+21,960
New +$320K ﹤0.01% 1389
2021
Q1
Sell
-122,819
Closed -$3.35M 2070
2020
Q4
$3.35M Buy
+122,819
New +$3.35M 0.05% 469
2020
Q1
Sell
-141,489
Closed -$2.01M 1524
2019
Q4
$2.01M Buy
+141,489
New +$2.01M 0.05% 337
2019
Q2
Sell
-30,500
Closed -$691K 1243
2019
Q1
$691K Sell
30,500
-50,800
-62% -$1.15M 0.02% 609
2018
Q4
$1.84M Sell
81,300
-19,700
-20% -$446K 0.07% 347
2018
Q3
$2.9M Buy
+101,000
New +$2.9M 0.13% 215
2017
Q1
Sell
-30,418
Closed -$576K 742
2016
Q4
$576K Sell
30,418
-10,175
-25% -$193K 0.07% 314
2016
Q3
$909K Buy
+40,593
New +$909K 0.15% 187